Autoinjectors or auto-injector is a medical device, which is used to deliver a particular dosage of a drug. These devices are easy-to-handle & cost-effective and can be used by patients, caregivers, and even untrained personnel to deliver drugs of definite dosage. Autoinjectors are used for several applications, namely, rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and other therapies. These devices offer multiple advantages over its conventional counterparts, namely accuracy, better efficacy, lower probability of needle-stick injuries, consistent dosage delivery, simplicity and safety among others.
Market Industry Reports (MIR) has published a new report titled "Autoinjectors Market - Global Industry Analysis, Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030"." According to the report, the global autoinjectors market is anticipated to grow at a CAGR of 19.0% from 2019 to 2030.
Major Key Players of the Autoinjectors Market are:
Abbvie, Mylan, ELI Lilly, Ypsomed, Amgen, Becton Dickinson and Company, Owen Mumford, Consort Medical, Haselmeier and Shl Group among others.
Read More @ http://www.sbwire.com/press-releases/autoinjectors-market-prospects-outlook-2019-2030-and-top-key-players-abbvie-mylan-eli-lilly-ypsomed-1279892.htm
Market Industry Reports (MIR) has published a new report titled "Autoinjectors Market - Global Industry Analysis, Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030"." According to the report, the global autoinjectors market is anticipated to grow at a CAGR of 19.0% from 2019 to 2030.
Major Key Players of the Autoinjectors Market are:
Abbvie, Mylan, ELI Lilly, Ypsomed, Amgen, Becton Dickinson and Company, Owen Mumford, Consort Medical, Haselmeier and Shl Group among others.
Read More @ http://www.sbwire.com/press-releases/autoinjectors-market-prospects-outlook-2019-2030-and-top-key-players-abbvie-mylan-eli-lilly-ypsomed-1279892.htm
The global autoinjectors market is driven by growing popularity of targeted therapies and increasing number of regulatory approvals. Moreover increasing incidences of anaphylaxis, availability of generic versions of autoinjectors and growing geriatric population is anticipated to further contribute to the growing demand of the global autoinjectors market during the forecast period. However, availability of conventional drug delivery systems like syringes s likely to restrain the market to a certain extent.
The advent of novel technologies in the field of autoinjectors has been pivotal in contributing to the growing demand of these devices worldwide. Adoption of latest technologies like variable dose drug delivery and feedback mechanism on time and dosage of drugs have been extremely beneficial in supporting the growth of this industry. For instance, SmartPilot technology for YpsoMate product line, manufactured by Ypsomed AG, offers several advanced features which enables administration of drugs with better efficiency and efficacy. Features like drug identification, reminder of injection time and date, variable dosage delivering capacity and feedback systems have raised the standards of drug delivery technologies, which is further anticipated mature in the coming years.
The advent of novel technologies in the field of autoinjectors has been pivotal in contributing to the growing demand of these devices worldwide. Adoption of latest technologies like variable dose drug delivery and feedback mechanism on time and dosage of drugs have been extremely beneficial in supporting the growth of this industry. For instance, SmartPilot technology for YpsoMate product line, manufactured by Ypsomed AG, offers several advanced features which enables administration of drugs with better efficiency and efficacy. Features like drug identification, reminder of injection time and date, variable dosage delivering capacity and feedback systems have raised the standards of drug delivery technologies, which is further anticipated mature in the coming years.
No comments:
Post a Comment